Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

20 May 2004

Coagulation inhibitors – antithrombin and protein C and periventricular leukomalacia in premature infants

Iwona Sadowska-Krawczenko, Małgorzata Ćwiklińska-Jurkowska, Piotr Korbal, Wiesław Szymański

Med Sci Monit 2004; 10(2): 88-91 :: ID: 11852

Abstract

Background: Despite the great progress in neonatology since the 1990s, brain injury and neurodevelopmental impairment in the newborns remain common. Cranial imaging and neuropathology data indicate that periventricular leukomalacia can coexist with periventricular-intraventricular haemorrhage but they also may have separate pathogenic mechanisms. PVL refers to necrosis of the periventricular matter adjacent to the external angles of the lateral ventricles. The pathogenesis of this lesion relates to three major interacting factors: an incomplete state of development of the vascular supply to the cerebral white matter, a maturation-dependent impairment in regulation of cerebral blood flow and the maturation-dependent vulnerability of the oligodendroglial (OL) precursor cell that represents the major cellular target in PVL. The purpose of our study was to evaluate possible correlation between coagulation inhibitors and periventricular leukomalacia. Material/Methods: Serum samples were tested from 189 premature infants 20–30 minutes after delivery and on the 3rd day of life. Following laboratory tests were performed: C- reactive protein (12 hours after delivery), blood gases, blood cell count with smear, antithrombin activity, protein C activity, electrolytes. Arterial blood pressure was also measured.Results: 19 of 189 newborns were diagnosed with PVL according to cranial ultrasonography and neurological examination performed at the age of 2 months. In the group of children with PVL we have found lower activity of antithrombin and protein C in comparison to children without PVL.Conclusions: Etiology of periventricular leukomalacia is multifactorial and we conclude that activation of coagulation may have a significant effect on the patophysiology of this complication.

Keywords: antithrombin, periventricular leukomalacia, Protein C

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750